Harvard Health notes that gastrointestinal symptoms are among the most common GLP-1 side effects
We excluded patients with bariatric surgery history and required weight measurements during baseline (90 days pre-treatment), the first year post-treatment (year 1), and the second year post-treatment (year 2), yielding 34,143 semaglutide-treated and 16,034 tirzepatide-treated patients ( Figure S1 )
Inflammatory bowel disease during active flares GI side effects can be hard to distinguish from disease activity, and tolerability can be lower during flares
Some individuals may be eager to try the medication without going through the traditional healthcare system, which can involve consultations, assessments, and potential waiting times
Regular application can lead to a more even complexion, making the skin appear radiant and youthful
We also explored differences between key population subgroups